The Food and Drug Administration (FDA) has not approved stem cell therapy for amyotrophic lateral sclerosis (ALS). However, people could participate in clinical trials involving this ALS treatment.

A new study published in Scientific Reports indicates that amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) have an extremely high geographic association, even after controlling for ...

Amyotrophic lateral sclerosis (ALS) is a devastating, fatal neuromuscular disease. Most patients die within 2 to 5 years of diagnosis. The disease stems from death of upper and lower motor neurons ...

Infrared analyses of neuronal proteins provide information on molecular changes in patients with ALS. This helps to verify their diagnosis. A research team from the Centre for Protein Diagnostics ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

Amyotrophic Lateral Sclerosis, ALS, is a horrible disease. Last week in a reversal of a decision the FDA made just a few months ago, their external advisory board approved a “novel” drug for ALS. What ...

Scientists at Cedars-Sinai report they have developed a new resource to help identify new subtypes of amyotrophic lateral sclerosis (ALS). The web-based tool is part of a collaborative effort with ...

Amyotrophic lateral sclerosis (ALS) is a life-threatening neurodegenerative disorder with a two- to three-year median survival after the appearance of symptoms. ALS mainly affects upper and lower ...

Forty-one-year-old Andres Albaladejo noticed a bizarre symptom in his left arm, which he ignored, thinking it was nothing more than a usual nerve issue. However, little did he know that it was the ...

SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment of amyotrophic ...